Department of Health Surveillance and Bioethics, Section of Legal Medicine, Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
Cardiovascular Genetics Centre, University of Girona-IDIBGI, 17190, Salt, Spain.
Int J Legal Med. 2024 Nov;138(6):2229-2237. doi: 10.1007/s00414-024-03264-6. Epub 2024 Jun 7.
Sudden infant death syndrome (SIDS) is still the leading cause of death for newborns in developed countries. The pathophysiological mechanisms have not been fully clarified, but in some of SIDS cases variants of genes associated with inherited cardiac conditions are found. In this study, an analysis of SCD-related genes was performed to determine the prevalence of rare pathogenic (P) or likely pathogenic (LP) variants that could provide an unambiguous explanation for the fatal event. A cohort of 76 SIDS cases underwent Next-Generation Sequencing (NGS) analysis with a custom panel of SCD-related genes. Rare variants were classified according to the guidelines provided by the American College of Medical Genetics and Genomics (ACMG) and the specifications of the ClinGen association. Post-mortem genetic testing identified 50 (65.8%) carriers of at least one variant in SCD genes. 104 rare genetic variants were found, 65.4% in genes encoding structural proteins. Only 4 out of 76 cases (5.3%) hosted at least a P or LP variant found in genes with structural or structural/arrhythmogenic functions (SLC22A5, SCN5A, MYL3and TTN). 99 variants were classified as of uncertain significance (VUS). The difference in the distribution of variants between gene groups by function was not statistically significant (chi square, p = 0,219). Despite this, most of the variants concerned structural genes that were supposed to have a close interaction with ion channels, thus providing an explanation for the arrhythmic event. Segregation analysis, reclassification of VUS variants and identification of new associated genes could clarify the implications of the current findings.
婴儿猝死综合征(SIDS)仍然是发达国家新生儿死亡的主要原因。其病理生理机制尚未完全阐明,但在一些 SIDS 病例中发现了与遗传性心脏疾病相关的基因变异。在这项研究中,对 SCD 相关基因进行了分析,以确定罕见的致病性(P)或可能致病性(LP)变异的患病率,这些变异可以为致命事件提供明确的解释。对 76 例 SIDS 病例进行了下一代测序(NGS)分析,使用了 SCD 相关基因的定制面板。根据美国医学遗传学与基因组学学院(ACMG)提供的指南和 ClinGen 协会的规范对罕见变异进行了分类。尸检后的基因检测发现 50 例(65.8%)至少携带一种 SCD 基因变异。共发现 104 种罕见遗传变异,其中 65.4%存在于编码结构蛋白的基因中。在 76 例病例中,只有 4 例(5.3%)至少携带一种具有结构或结构/致心律失常功能的基因(SLC22A5、SCN5A、MYL3 和 TTN)中的 P 或 LP 变异。99 种变异被归类为意义不明的变异(VUS)。按功能分组的基因变异分布差异无统计学意义(卡方检验,p=0.219)。尽管如此,大多数变异都涉及结构基因,这些基因应该与离子通道有密切的相互作用,从而为心律失常事件提供了一个解释。分离分析、VUS 变异的重新分类和新相关基因的鉴定可以阐明当前发现的意义。